• Primary myelofibrosis (PMF)
  • Polyoma BK Virus, PCR, Quantitative, Urine
  • Chronic Lymphocytic Leukemia (CLL), FISH, Blood
  • Solute carrier family 6 member 2 (SLC6A2)
  • Protein Immunofixation Electrophoresis, CSF
  • Chitotriosidase, Serum
  • Estrogen/Progesterone Receptor, IHC
  • HLA-B*57:01 Genotype, Abacavir Sensitivity
  • Genetic Testing for Severe Inherited Diseases, NGS
  • Human Chorionic Gonadotropin (HCG), Qualitative, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease)
Medical Test

Turnaround Time
Access to Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease) is restricted.